The branched chain amino acids in autism spectrum disorders (Record no. 373530)

000 -LEADER
fixed length control field 03451ntm a22003257a 4500
003 - CONTROL NUMBER IDENTIFIER
control field AT-ISTA
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190813140122.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180626s2018 au ||||| m||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Transcribing agency IST
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Tarlungeanu, Dora
9 (RLIN) 4258
245 ## - TITLE STATEMENT
Title The branched chain amino acids in autism spectrum disorders
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Name of publisher, distributor, etc. IST Austria
Date of publication, distribution, etc. 2018
500 ## - GENERAL NOTE
General note Thesis
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Abstract
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Acknowledgements
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note About the Author
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note List of Publications appearing in Thesis
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note List of Figures
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note List of Tables
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note List of Symbols/Abbreviations
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 1 Chapter 1 - Introduction
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 2 Chapter 2 -Genomics in neurodevelopmental disorders: an avenue to personalized medicine
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 3 Chapter 3 - Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 4 Chapter 4 - Conclusion and future directions
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 5 References
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 6 Appendix 1. Supplemental figures and tables
520 ## - SUMMARY, ETC.
Summary, etc. Autism spectrum disorders (ASD) are a group of genetic disorders often overlapping with other neurological conditions. Despite the remarkable number of scientific breakthroughs of the last 100 years, the treatment of neurodevelopmental disorders (e.g. autism spectrum disorder, intellectual disability, epilepsy) remains a great challenge. Recent advancements in genomics, like whole-exome or whole-genome sequencing, have enabled scientists to identify numerous mutations underlying neurodevelopmental disorders. Given the few hundred risk genes that were discovered, the etiological variability and the heterogeneous phenotypic outcomes, the need for genotype- along with phenotype-based diagnosis of individual patients becomes a requisite. <br/><br/>Driven by this rationale, in a previous study our group described mutations, identified via whole-exome sequencing, in the gene BCKDK – encoding for a key regulator of branched chain amino acid (BCAA) catabolism - as a cause of ASD. Following up on the role of BCAAs, in the study described here we show that the solute carrier transporter 7a5 (SLC7A5), a large neutral amino acid transporter localized mainly at the blood brain barrier (BBB), has an essential role in maintaining normal levels of brain BCAAs. In mice, deletion of Slc7a5 from the endothelial cells of the BBB leads to atypical brain amino acid profile, abnormal mRNA translation and severe neurological abnormalities. Additionally, deletion of Slc7a5 from the neural progenitor cell population leads to microcephaly. Interestingly, we demonstrate that BCAA intracerebroventricular administration ameliorates abnormal behaviors in adult mutant mice. Furthermore, whole-exome sequencing of patients diagnosed with neurological disorders helped us identify several patients with autistic traits, microcephaly and motor delay carrying deleterious homozygous mutations in the SLC7A5 gene. <br/><br/>In conclusion, our data elucidate a neurological syndrome defined by SLC7A5 mutations and support an essential role for the BCAAs in human brain function. Together with recent studies (described in chapter two) that have successfully made the transition into clinical practice, our findings on the role of BCAAs might have a crucial impact on the development of novel individualized therapeutic strategies for ASD.
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.15479/AT:ISTA:th_992">https://doi.org/10.15479/AT:ISTA:th_992</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
  Not Lost       Library Library 2018-06-26 AT-ISTA#001520 2018-11-06 2018-06-26 Book

Powered by Koha